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Abstract
Population specific associations between cardiovascular disease with various risk factors
including pre-hypertension and hypertension were reported. We aimed to investigate the
association of higher than optimal blood pressure with measures of dysglycemia, dyslipide-
mia, and markers of inflammation in non-diabetic Saudi adults hoping to improve current
Saudi guidelines to prevent cardiovascular disease. Volunteers were recruited randomly
from public healthcare centers in Jeddah. Demographic information, blood pressure (BP),
and anthropometric measurements were taken. Fasting blood samples were drawn, then
again following 1-hour oral glucose tolerance test. Glycated hemoglobin, fasting plasma glu-
cose (FPG), lipid profile, highly sensitive C- reactive protein, gamma glutamyl transferase,
and 1-hour plasma glucose were measured. Complete data was found for 742 men and 592
women. Pre-hypertension was found in 47.2% of men, and 24.7% of women, while 15.1% of
men, and 14.6% of women were hypertensive. Means of measured variables differed signifi-
cantly between normotensive, pre-hypertensive, and hypertensive groups of men and
women in gender specific manner. Association between measured variables and elevated
BP, and hypertension were assessed using logistic regression models. After adjustment for
age, body mass index and waist circumference, elevated blood pressure was associated
with elevated triglycerides in men, while hypertension was significantly associated with ele-
vated fasting plasma glucose, total cholesterol, triglycerides, low density lipoprotein- choles-
terol, and low high density lipoprotein- cholesterol in men, and elevated triglycerides, and
total cholesterol in women. Therefore, it is strongly recommended to measure lipid profile,
specifically TG, for all diagnosed pre-hypertensive and hypertensive patients in addition to
FPG for men.
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Background
Type 2 diabetes (T2D) is a risk factor for cardiovascular diseases (CVD) [1]. Dyslipidemia,
smoking, chronic inflammation, and abdominal obesity are also known risk factors for CVD
[2–6]. Moreover, various epidemiological studies have indicated that blood pressure (both dia-
stolic and systolic) is a most important risk factor, which has an independent, continuous, and
direct association with CVD outcomes [7–10]. Furthermore, the increased risk of CVD was
found to be associated with high-normal blood pressure (BP) values [11]. Obesity, hyperten-
sion, dyslipidemia and impaired glucose tolerance (IGT) had been found to cluster together
[12–17], thus suggesting the possibility of a common aetiological mechanism, with the associa-
tion between elevated BP and those other cardiovascular risk factors having long been
acknowledged [18]. It has also been reported that obesity, and abdominal obesity are risk fac-
tors for the other CVD risk factors: hypertension, dyslipidemia, and diabetes mellitus [19]. Evi-
dence for the relationship between increased weight and increased BP was reported much
earlier based on findings in the nationwide "Community Hypertension Evaluation Clinic
Screening" of more than 1 million men and women in the USA [20], and the "Framingham
Study", where it was demonstrated that BP increased in both men and women with increased
overweight [21]. These findings were verified later in a Canadian study especially in young
adults 18 to 34 years of age [22], and in female nurses in USA [23].
Moreover, the presence of other cardiovascular risk factors, which cause endothelial dys-
function, has been suggested to contribute to the pathophysiology of hypertension [24], and
studies of the association between hypertension and other CVD risk factors are numerous. A
Japanese study showed that high normal BP, and hypertension increased the risk of T2D [25].
In addition, elevated BP was found to be increased in people with impaired glucose tolerance
(IGT) in young, American, black adults [26]. Furthermore, a large meta-analysis of 4.1 million
people showed that high BP was associated with elevated incidence of T2D [3]. Moreover, a
more recent study reported that people with high BP are nearly 60% more likely to develop
T2D [27], and a longitudinal Chinese study reported that time-cumulated exposure to elevated
BP was significantly associated with an elevated incidence of IGT and diabetes [28]. Associa-
tion between dyslipedemia and elevated BP has also been investigated, and is well discussed by
Ruben et al (2006) [29]. Dyslipidemia leads to endothelial damage resulting in loss of vasomo-
tor activity, which could cause hypertension (Nickenig et al, 2002) [30]. Similarly, elevated BP
had been reported to be associated with inflammation in the general population [31, 32], and
even at the typically observed low levels of inflammation in the general population, there is an
association between the level of C-reactive protein (CRP), as a marker of inflammation, and
systolic BP (SBP) [33].
Studies on mentioned associations did not include people from the Arab world. Genetic
factors, and hence ethnicity play an important role in susceptibility to disease [34, 35], In an
earlier study, conducted in Jeddah, Saudi Arabia, [36], we reported an association between
above than normal weight with dysglycemia, and hypertension, which was gender specific.
Moreover, in another survey, conducted in the same city at a later date, high LDL-C was found
to be associated with an increased probability of pre-diabetes (Al amri et al 2019), which points
to the clustering of the three CVD risk factors, excess weight increased blood pressure and dys-
glycemia in the Saudi population, as noted in studies from other countries [12–17]. Up to date,
there are no official guidelines for laboratory investigations in non-diabetic people with hyper-
tension in Saudi Arabia. Therefore, we aimed at investigating the association between higher
than optimal blood pressure and other known laboratory measured risk factors for CVD,
including measures of dysglycemia, lipid profile, C-reactive protein (CRP) [37, 38], and
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gamma glutamyl transferase (GGT) [39–41], in a non- diabetic Saudi population in the hope
of providing evidence for improved management to prevent the progression to CVD.
Materials and methods
Study design and sample collection
Data included in this study were obtained from a survey conducted in the city of Jeddah
between July 2016 and February 2017. Approval was given by the Committee on the Ethics of
Human Research at the Faculty of Medicine-King Abdulaziz University, Jeddah (Reference
No. 338–10). A full explanation of sampling methodology has been outlined earlier [42], and is
summarized here as follows: non-diabetic adults (age�18 years) were recruited from attend-
ees of Primary Health Care (PHC) centers in Jeddah, Saudi Arabia. Following signing an
informed consent form, demographic, dietary, and lifestyle variables, as well as medical history
and family history of chronic diseases were collected from recruits using a predesigned ques-
tionnaire. Fasting blood sample was taken, for determination of fasting plasma glucose (FPG),
glycated hemoglobin (HbA1c), lipid profile, high-sensitivity CRP (hs-CRP) and GGT, followed
by 1-hour oral glucose tolerance test (OGTT) [43, 44] to screen for diabetes and pre-diabetes.
Anthropometric measurements [weight, height, waist circumference (WC)], and blood pres-
sure (BP) were measured using standardized equipment and techniques. Weight and height
were used to calculate the body mass index (BMI).
Biochemical assays
Whole blood, serum and plasma samples were sent regularly to an accredited laboratory by the
College of American Pathologist at the National Guard Hospital in Jeddah. Plasma glucose
and serum hs-CRP, GGT, total cholesterol (TC), high density lipoprotein-cholesterol
(HDL-C) and triglycerides (TG) levels were measured by spectrophotometric methods using
Architect c8000 auto-analyzer (ABBOTT- USA). Low-density lipoprotein- cholesterol
(LDL-C) was calculated using the Friedewald equation [45]. HbA1c was measured with high
pressure liquid chromatography (HPLC) using automated HbA1c analyzer G8 (TOSOH Cor-
poration-Japan).
a) Diagnosis of pre-hypertension and hypertension. Pre-hypertension was defined
according to recommendations by the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure (JNC) VII report [46] as systolic blood
pressure: 120 to 139 mm Hg, and diastolic blood pressure 85 to 89 mm Hg, while hyperten-
sion was defined as SBP�140 and/or DBP�90 mm Hg or taking antihypertensive drug
treatment.
Statistical analysis
IBM SPSS statistics version 20.0 for Windows was used to enter and analyze collected data.
The baseline characteristics of study population were calculated statistically and described as
mean, standard deviations (SD), and frequencies.
Demographic, lifestyle and clinical factors of elevated blood pressure were analyzed by
comparing participants who were identified to have pre-hypertension or hypertension and
those with normal blood pressure. Factors with continuous variables were analyzed using
ANOVA to compare the three groups, and independent t-test to compare two groups, while
those with categorical variables were analyzed using Chi-square test or Fisher’s exact test, as
appropriate. Fisher’s exact test was applied when the number of people per cell was 5 or less.
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Unadjusted and adjusted logistic regression models were used for assessing association
between laboratory measured risk factors for CVD and outcome variables: elevated BP, and
hypertension.
Results
A total of 1733 adults were approached, but only 1477 adults accepted to participate and were
originally recruited. Individuals were excluded when laboratory samples were missing for vari-
ous reasons (hemolysis, missing labels, or broken tubes). After laboratory analysis of collected
blood samples, and excluding those discovered to have previously undiagnosed diabetes, as
well as excluding cases with missing data, complete data for the present analysis were available
for 1334 individuals, 742 men and 592 women. Due to the exclusion criteria, very few of the
included people (11 men and 7 women) were >64 years of age. Details of the different stages
of sample collection are outlined in (Fig 1).
Demographic, clinical, and biochemical characteristics of study population are presented in
Table 1 for men, and Table 2 for women:
Hypertensive men and women were significantly older than their pre-hypertensive and
normotensive counterparts. Moreover, means of BMI, and WC, of both pre-hypertensive, and
hypertensive groups of men or women were significantly higher than those of their respective
normotensive groups.
The means of all measures of glycemia (FPG, 1-h PG, and HbA1c) were all significantly
higher in hypertensive compared with normotensive groups of men. However, only the means
of FPG and 1-h PG in hypertensive group of women were significantly higher than those of
the normotensive group. The percentages of men or women with IGT were significantly
higher in the hypertensive groups compared with their respective normotensive groups.
The means of TC, hs-CRP, and GGT of pre-hypertensive and hypertensive groups of men
were significantly higher than the means of normotensive group. Moreover, a higher percent-
age of elevated GGT (Saudi upper limit for men is 86 UL) [47] was also noted in both the pre-
hypertensive (6.2%) and hypertensive (4.5%) compared with normotensive (1.8%) group of
men. However, the means of TG, and LDL-C were found to be significantly higher, and that of
HDL-C lower only in the group of hypertensive men compare to the corresponding means in
the normotensive group.
Different results were obtained for women. Only the means of TC, TG, LDL-C, and hs-
CRP in the hypertensive group of women were significantly higher than those corresponding
means in the normotensive group. In addition, the mean TG was significantly higher in the
pre-hypertensive group compared with that of the normotensive group. Elevated GGT (Saudi
upper limit for women> 30 UL) [47] was noted in the normotensive group (8.4%), as well as
the pre-hypertensive (7.7%) and hypertensive (10.7%) groups of women.
Following multiple logistic regression, the unadjusted odds ratio (OR) and confidence
interval (CI) and those adjusted for age alone, and again for age, BMI and WC for the associa-
tion between the combined groups of people with higher than acceptable BP (pre-hypertension
and hypertension), as well as the hypertensive groups alone with CVD risk covariates in men
and women is presented in Tables 3 and 4, respectively:
After adjusting for age, elevated TG, hs-CRP, and GGT remained significantly associated
with higher than optimal blood pressure in men, but no association was noted in women.
After adjusting for age, BMI, and WC, only elevated TG remained significantly associated with
higher than optimal blood pressure in men, while no significant associations remained in
women with any of the measured variables (Table 3).
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After adjusting for age only, elevated FPG, TC, TG, LDL-C, and low HDL- C remained sig-
nificantly associated with hypertension in men, but only elevated TC, TG and LDL-C main-
tained association in women. After adjusting for age, BMI, and WC, elevated FPG, TC, TG
and LDL- C, as well as low HDL-C remained significantly associated with hypertension in
men, while in women an association was found only for elevated TG and TC (Table 4)
Discussion
Increased risks of CVD and mortality are associated with higher than optimal blood pressure
[7–10]. The risk has been reported to be further increased when combined with diabetes or
pre-diabetes in Chinese population [48]. The presence of other risk factors for CVD, such as
chronic inflammation, and dyslipidemia, in addition to increased blood pressure might raise
the risk of the disease further [49]. However, there are differences in relative weight of CVD
risk factors between ethnic groups [50], and there are no such studies conducted on Saudi
Fig 1. Outline of the different stages of sample collection. A total 37.7% of men and 61% of women had normal blood pressure. Elevated BP
was mainly due to increased SBP in both sexes.
https://doi.org/10.1371/journal.pone.0246568.g001
Table 1. Demographic, clinical and biochemical characteristics of men by the study groups presented as mean ± standard deviation (SD).
Variable Non-hypertensive (Mean






Age (years) 29.2 ± 9.0 29.9 ± 8.8 37.2 ± 14.3b <0.001
BMI (kg/m2) 25.6 ± 0.3 28.0 ± 5.7a 30.4 ± .67b <0.001
Waist Circumference (cm) Individuals with high values (WC
>94 cm), (n,%)
91.5 ± 13.8 (124), 44.4% 97.7 ± 14.9a(204), 59.0% 104.4 ± 16.6b(80), 74.1% <0.001
<0.001
SBP(mean ± SD)
Individuals with high values (SBP� 120 mmHg), (n,%)
110± 6.4 125 ± 5.6a
(343), 98.0%
137± 15.3b(104), 92.9% <0.001
<0.001
DBP
Individuals with high values (DBP� 85 mmHg), (n,%)
68 ± 9.10 76 ± 8.0a
(50), 14.3%
88 ± 11.7b(77), 68.5% <0.001
<0.001
FPG, mmol/l
Individuals with high values (FPG�6.1mmol/l), (n,%)
4.2± 0.74
(1), 0.4%
4.0 ± 1.21a(2), 0.8% 4.6± 0.94b(9), 6.9% <0.001
<0.001
1-h, PG mmol/l
Individuals with high values (1-h, PG�8.6mmol/l), (n,%)
6.3± 1.83
(29),11.2%
5.9 ± 2.34a(36),11.4% 7.0 ± 1.91b(22), 22.7% <0.001
0.010
HbA1c, %
Individuals with high values (HbA1c�5.7%), (n,%)
mmol/mol









5.3 ± 0.43b(18), 17.8%





Individuals with IGT with any definition (FBG�6.1mmol/l
or 1-h, PG�8.6mmol/l or HbA1c�5.7%) (n,%)
(46), 16.4% (63), 18.0% (37), 33.3% 0.001
TC (mmol/L) 4.65 ± 0.99 4.86 ± 0.92a 4.93 ± 0.90b 0.006
TG (mmol/L) 1.28 ± 0.96 1.41 ± 1.00 1.74 ± 1.03b 0.000
HDL- C (mmol/L) 1.26 ± 0.23 1.28 ± 0.26 1.18 ± 0.24b 0.001
LDL- C (mmol/) 3.15 ± 0.94 3.29 ± 0.82 3.41 ± 0.86b 0.021
hs-CRP (mg/L) 2.41 ± 3.04 3.22 ± 3.58a 3.54 ± 3.95b 0.003
GGT (IU/L) 28.63 ± 18.04 37.53 ± 32.64a 38.83 ± 24.68b <0.001
n, number of subjects in subgroup; FPG, fasting plasma glucose; 1-hPG, 1-hour plasma glucose; TC, serum total cholesterol; HDL- C, serum high density lipoprotein
cholesterol; LDL, serum low density lipoprotein cholesterol; TG, serum triglycerides; hs-CRP,serum highly sensitive C-reactive protein; GGT, gamma glutamyl
transferase; P value of ANOVA test for differences between the three groups
a: P<0.05 between normal and pre-hypertensive groups
b: P<0.05 between normal and hypertensive groups
https://doi.org/10.1371/journal.pone.0246568.t001
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population in spite of the high prevalence of pre-hypertension and hypertension as reported
earlier [51–53], and as noted also in this study, as well as the high prevalence of diabetes and
pre-diabetes among the Saudis [54]. Therefore, this study was conducted to investigate an
important aspect related to improvement in healthcare, namely the association between higher
than optimal blood pressure and other known laboratory measured risk factors of CVD in our
population, in the hope of formulating guideline for necessary basic laboratory tests that
should be requested by practitioners treating non diabetic patients with higher than optimal
blood pressure.
A high percentage of our study population had elevated blood pressure, with only 37.7% of
men, and 61% of women having normal values, and with pre-hypertension being present in
47.2% of men, and 24.7% women, while 15.1% of men and 14.6% of women and were hyper-
tensive. In the latest Saudi national survey conducted in 2013 [52], 15.2% and 40.6% of Saudis
aged 15 years or older were hypertensive or borderline hypertensive, which is close to our find-
ings. Furthermore, similar to our findings, the same survey reported higher risk of hyperten-
sion among men compared to women [52]. In addition, a lower prevalence of hypertension
and pre-hypertension among women compared to men was also reported in a more recent
Saudi study [51]. This is in agreement with reports from studies in other countries in the
region [55], as well as older studies on populations from different parts of the globe [56].
Table 2. Demographic and biochemical characteristics of women by studied groups presented as mean ± standard deviation (SD).
Variable Non-hypertensive (Mean






Age (years) 31.4 ± 10.5 33.5 ± 12.3a 40.9 ± 14.3b <0.001
BMI (kg/m2) 26.0 ± 5.6 28.7 ± 6.4a 31.1 ± 7.5b <0.001
Waist Circumference (cm)
Individuals with high values (WC>80 cm), (n,%)
84.3±14.3 (202), 57.7% 91.4 ±16.3a
(109), 77.3%
98.0 ±0.162b(75), 88.2% <0.001
<0.001
SBP(mean ± SD)
Individuals with high values (SBP� 120 mmHg), (n,%)
104 ± 8.2 122 ± 4.9a
(135), 92.5%
133 ± 18.7b(72), 84.7% <0.001
<0.001
DBP
Individuals with high values (DBP� 85 mmHg), (n,%)
65 ± 7.9 75 ± 8.8a
(22), 15.1%
87 ± 11.7b(57), 67.1% <0.001
<0.001
FPG, mmol/l





4.4 ± 0.77b(5), 5.9% 0.117
0.019
1-h PG mmol/l










Individuals with high values (HbA1c�5.7%), (n,%)
Mmol/mol

















Individuals with IGT with any definition (FBG�6.1mmol/l or
1-h, PG�8.6mmol/l or HbA1c�5.7%) (n,%)
(62), 17.2% (23), 15.8% (28), 32.9%b 0.002
TC (mmol/L) 4.76± 0.93 4.80 ± 0.88 5.13 ± 0.98b 0.004
TG (mmol/L) 0.96 ± 0.48 1.08 ± 0.63a 1.30 ± 0.70b <0.001
HDL- C (mmol/L) 1.48 ± 0.28 1.48 ± 0.32 1.45 ± 0.25 0.542
LDL- C (mmol/) 3.09 ± 0.81 3.12 ± 0.83 3.43 ± 0.84b 0.003
hs-CRP (mg/L) 3.42 ± 3.84 4.02 ±4.40 5.13 ± 5.07b 0.004
GGT (IU/L) 17.82 ± 18.19 19.08 ± 13.09 21.85 ± 26.42 0.195
n, number of subjects in subgroup; FPG, fasting plasma glucose; 1-hPG, 1-hour plasma glucose; TC, serum total cholesterol; HDL- C, serum high density lipoprotein
cholesterol; LDL, serum low density lipoprotein cholesterol; TG, serum triglycerides; hs-CRP,serum highly sensitive C-reactive protein; GGT, gamma glutamyl
transferase; P value of ANOVA test for differences between the three groups
a: P<0.05 between normal and pre-hypertensive studied groups
b: P<0.05 between normal and hypertensive studied groups
https://doi.org/10.1371/journal.pone.0246568.t002
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Aging is well-known to be associated with increased risk of hypertension in various popula-
tions [57–59], and also noted in previous Saudi studies [51–53]. In concordance with this, the
mean age of people with hypertension in our study was significantly higher than the mean age
of normotensive people. In addition, the means of BMI and WC in the hypertensive and pre-
hypertensive people were significantly higher than the corresponding means of those with nor-
mal BP. Overweight and obesity, especially when accompanied with abdominal obesity, are
major causes of hypertension [60–62]. In previous Saudi studies, higher than normal weight
was reported to be associated with increased prevalence [53] and increased risk of hyperten-
sion [51, 52]. However, these studies had not investigated sex differences in risk assessment,
nor did they adjust for age when reporting association. In an earlier survey conducted in Jed-
dah by our group, obesity and overweight were found to be associated with an increased risk
of hypertension in men but not in women after adjusting for age [36]. Therefore, in this study
while investigating the association between increased blood pressure and laboratory measured
CVD risk factors, age alone, as well as age, BMI and WC were adjusted for to account for their
possible influence on results.
After adjustment for age, elevated TG, hs-cRP, and GGT remained significantly associated
with higher than optimal blood pressure (pre-hypertension and hypertension combined) in
men, but no association was noted in women. However, following similar adjustment, elevated
FPG, TC, TG, LDL-C, and low HDL-C remained significantly associated with hypertension in
men, but only elevated TC, TG and LDL-C maintained association in women.
Table 3. Unadjusted, age adjusted, and age, BMI and WC adjusted odds ratio (OR) and confidence interval (CI) for CVD risk covariates associated with pre-hyper-
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After adjustment for age, BMI and WC, above than optimal blood pressure (pre-hyperten-
sion and hypertension combined) was associated only with increased level of serum TG in
men but not women. However, following similar adjustments, hypertension was significantly
associated with elevated FPG, TC, TG, and LDL-C, as well as low HDL-C in men, while signifi-
cant association was found only for elevated TG, and TC in women. These results emphasize
gender differences in our population, and should be taken into account when considering
management.
However, no significant association was found between high blood pressure and hs-CRP or
GTT, even though both are considered as markers of inflammation and are associated with
increased risk of CVD. Indeed, serum CRP level is reported to be a powerful predictor of ische-
mic CVD events in apparently healthy subjects, as well as in patients with stable or unstable
angina [37, 38]. Furthermore, CRP and blood pressure are considered to be independent
determinants of CVD risk, increasing the risk when combined [63, 64]. In addition, the same
group of researchers, as well as others reported that CRP level was positively associated with
systolic blood pressure, and hypertension [63, 64]. However, another study contradicted this
and found that elevated CRP levels were not associated with, and did not appear to lead to ele-
vated blood pressure, after adjustment for various confounders [65], which substantiates our
results when adjustment was made for age, BMI and WC.
GGT has been reported to be involved in the pathogenesis of hypertension in a Chinese
three-year follow-up study on normotensive and hypertensive subjects [66], while another
Chinese study reported that GGT showed strong positive correlations with systolic blood
Table 4. Unadjusted, age adjusted, and age, BMI and WC adjusted odds ratio (OR), and confidence interval (CI) for CVD risk covariates associated with hyperten-
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pressure and diastolic blood pressure [67]. In addition, a Korean study reported that high
serum GGT levels, and even high normal level, were associated with a higher risk of incident
hypertension, particularly in alcohol drinkers and non-overweight individuals [68]. Moreover,
young patients with pre-hypertension were reported to have higher serum GGT levels com-
pared with healthy subjects in a small case-control study in Turkey [69]. In our study, elevated
levels of GGT was noted also among normotensive women, in addition to women with high
blood pressure, while pre-hypertensive and hypertensive men had a significantly higher mean
level of GGT compared with normotensive men. Additionally, in this study an association
with higher than optimal blood pressure was found after adjustment for age only in men, but
not women. Yet, after adjusting for age, BMI and WC no significant association was found
between GGT and higher than optimal blood pressure. A recent meta-analysis evaluating asso-
ciation between development of hypertension and GGT level found that the reported direct
association between GGT level and risk of hypertension was more significant in Asians and
male subgroups compared to non-Asians and female subgroups, explaining this by the fact
that Asians have more prevalence of hepatic diseases, which was not accounted for in these
studies, and that men drink more alcoholic beverages than women in the studied populations
[70]. In addition, when they performed subgroup analysis in non-drinkers, only a non-statisti-
cally significant increased trend was found, which is comparable to our results since our study
participants were non-drinkers.
The Saudi Hypertension Guidelines 2018 [71] recommended the measurement of complete
lipid profile, and fasting blood glucose in all diagnosed hypertensive patients as basic investiga-
tions to improve management and decrease risk of CVD. This is in keeping with the European
[72] and American [46] guidelines. However, these guidelines were not endorsed by the "Saudi
Ministry of Health", and hence, have not been adhered to strictly, leaving the matter to the
interest and judgment of the treating physician. Furthermore, there are no specific Saudi
guidelines for basic investigations in the case of pre-hypertension, which means that no spe-
cific laboratory investigations are usually requested. As mentioned earlier, the risk of CVD is
very much increased when combined with diabetes or pre-diabetes [48], especially with ele-
vated post-challenge glucose. Indeed, the co-existence of multiple CVD risk factors in any per-
son results in an effect that is greater than the sum of the effects of its individual components
[72], leading to a shift towards higher risk stratification and necessitating different manage-
ment strategy to prevent, or at least delay, the development of CVD, which contributes to 31%
of all deaths globally [73], and to 45% of all deaths in Saudi Arabia (Al Habib, 2020) [74]
mainly due to poor preventive management strategies. Therefore, this study provides impor-
tant, evidence based information, much needed in our region to improve measures for the pre-
vention of CVD by guiding treating physicians to the most likely required set of tests for risk
stratification, and hence improved management.
Our study has a few limitations. The first one is common to all cross-sectional studies
where only an association between studied variables, but not causation, can be inferred.
Another limitation is that only few people were included in the older age group (>64 years)
due to being already diagnosed with diabetes one of the conditions in the exclusion criteria.
Strengths of our study include the involvement of well-trained data collectors and the use of
well-standardized methods for data collection. Secondly, to avoid bias, PHCCs and partici-
pants were selected randomly. Moreover, accuracy of laboratory results was assured by con-
ducting all measurements in one accredited laboratory.
In conclusion, based on our results, hypertensive men and women, and pre-hypertensive
men are more likely to have dyslipidemia, increasing their risk for CVDs. Furthermore, hyper-
tensive men are more likely to have impaired fasting glucose with a further increase in risk.
Therefore, it is highly recommended that all physicians include the estimation of lipid profile
PLOS ONE The association between hypertension and other cardiovascular risk factors
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and fasting plasma glucose in their routinely requested tests for all diagnosed hypertensive
patients. In addition, the estimation of fasting serum TG at least, if not lipid profile, should be
requested for all pre-hypertensive men. Failure to do so is expected to lead to less than optimal
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